Dra. Ruth Gil Prieto

Filiación

Catedrática de Universidad. Área de Medicina Preventiva y Salud Pública. Departamento de Especialidades Médicas y Salud Pública. Universidad Rey Juan Carlos. Madrid.

Biografía

Education:
Master in Epidemiology & Public Health
University/College of Higher Education: Rey Juan Carlos. Madrid
Date: 2006/2008
PhD in Epidemiology and Public Health (Extraordinary award for the best PhD thesis of the year)
University/College of Higher Education: Rey Juan Carlos
Date: 7 July 2006
Supervisor (‘Promotor’): Prof. Dr. A. Gil de Miguel
Title of thesis: Seroepidemiological study to assess the prevalence of
hyperhomocisteinaemia in scholar population of 13-15 years
old in Madrid (Spain)
Bachelor in Biochemistry
University/College of Higher Education: Complutense University. Madrid (Spain)
Date: July 2003
Since 12/2018 Professor in Epidemiology and Prevention of Infectious Diseases:
vaccinology, Department of Medical Specialities & Public Health,
Universidad Rey Juan Carlos
02/2011-12/2018 Associate professor (tenured) in Epidemiology and Prevention of
Infectious Diseases: vaccinology, Department of Preventive
Medicine & Public Health, Universidad Rey Juan Carlos
03/2014-04/2021 Director of the Program of Cooperation and International
Volunteering, Universidad Rey Juan Carlos
03/2012-07/2013 Visiting associate professor, Department of Population Medicine
Harvard Medical School & Harvard Pilgrim Health Care
12/2007-01/2011 Associate professor, Department of Preventive Medicine & Public
Spanish: Native speaker
English: High command in written and spoken English
French: Medium-level of written and spoken French.
German Low-level of written and spoken German
Personal Details:
Education:
Work experience:
Languages:
Curriculum vitae 2022 Ruth Gil-Prieto
2
Selected projects:
 Cathedra of Vaccinology with: PFIZER-URJC
 Emerging research group in epidemiology and diagnosis of infectious diseases at the Rey Juan Carlos
University.
 Methodological support for research at the University Hospital of Fuenlabrada.
 Space time statistics for immunopreventable diseases outbreak detection and monitoring with
administrative hospitalization databases.
 Study to assess the hospital morbidity of immunopreventable diseases in Spain.
Selected projects:
 COronavirus Vulnerabilities and INFOrmation dynamics Research and Modelling. European Comission
 Immunological biomarkers in serum associated with SARS-Cov-2 virus injection.
Peer-reviewed Articles (+85). Selection:
González-López JJ, Álvarez Aldeán J, Álvarez García FJ, Campins M, Garcés-Sánchez M, Gil-Prieto R, Grande-
Tejada AM. Epidemiology, prevention and control of pertussis in Spain: New vaccination strategies for
lifelong protection. Enferm Infecc Microbiol Clin (Engl Ed). 2022 Apr;40(4):195-203. doi:
10.1016/j.eimce.2021.04.009. PMID: 35473991 Review.
Heppe-Montero M, Walter S, Hernández-Barrera V, Gil-Prieto R, Gil-de-Miguel Á. Burden of respiratory
syncytial virus-associated lower respiratory infections in children in Spain from 2012 to 2018. BMC
Infect Dis. 2022 Mar 31;22(1):315. doi: 10.1186/s12879-022-07261-1. PMID: 35361139
Candel FJ, Canora J, Zapatero A, Barba R, González Del Castillo J, García-Casasola G, San-Román J, Gil-Prieto
R, Barreiro P, Fragiel M, Prados F, Busca P, Vázquez-Castro J, Marco J. Temporary hospitals in times
of the COVID pandemic. An example and a practical view. Rev Esp Quimioter. 2021 Mar
22:candel22mar2021. doi: 10.37201/req/041.2021.
Baral S, Chandler R, Prieto RG, Gupta S, Mishra S, Kulldorff M. Leveraging epidemiological principles to
evaluate Sweden's COVID-19 response. Ann Epidemiol. 2021 Feb;54:21-26. doi:
10.1016/j.annepidem.2020.11.005. Epub 2020 Nov 23.
Charle-Cuéllar P, López-Ejeda N, Traore M, Coulibaly AB, Landouré A, Diawara F, Bunkembo M, Vargas A,
Gil R, Briend A. Impact of Different Levels of Supervision on the Recovery of Severely Malnourished
Children Treated by Community Health Workers in Mali. Nutrients. 2021 Jan 26;13(2):367. doi:
10.3390/nu13020367
Heppe Montero M, Gil-Prieto R, Walter S, Aleixandre Blanquer F, Gil De Miguel Á. Burden of severe
bronchiolitis in children up to 2 years of age in Spain from 2012 to 2017. Hum Vaccin Immunother.
2022 Dec 31;18(1):1883379. doi: 10.1080/21645515.2021.1883379. Epub 2021 Mar 2. PMID:
33653212
Candel FJ, Viñuela-Prieto JM, González Del Castillo J, Barreiro García P, Fragiel Saavedra M, Hernández Píriz
A, Jiménez Virumbrales D, Canora Lebrato J, García de Casasola G, Gil Prieto R, San-Román Montero
J, Ortega Anselmi J, Barba Martín R, Prados Roa F, Marco Martínez J, Zapatero Gaviria A. Utility of
lateral flow tests in SARS-CoV-2 infection monitorization. Rev Esp Quimioter. 2020 Aug;33(4):258-
266. doi: 10.37201/req/052.2020. Epub 2020 Jun 4.
Gil-Conesa M, Del-Moral-Luque JA, Gil-Prieto R, Gil-de-Miguel Á, Mazzuccheli-Esteban R, Rodríguez-
Caravaca G. Hospitalization burden and comorbidities of patients with rheumatoid arthritis in Spain
during the period 2002-2017. BMC Health Serv Res. 2020 May 4;20(1):374. doi: 10.1186/s12913-020-
05243-0.
Research projects as principal investigator: +20
Publications:
Research projects as investigator: +40
Curriculum vitae 2022 Ruth Gil-Prieto
3
San Román Montero J, Gil-Prieto R, Martín RJ, de Lejarazu RO, Gallardo-Pino C, Gil de Miguel A. Influenza
hospitalizations in children under 1 year old in Spain: the importance of maternal immunization. Hum
Vaccin Immunother. 2021 Jun 3;17(6):1853-1857. doi: 10.1080/21645515.2020.1845523. Epub 2020
Dec 22.
Arias-Fernández L, Gil-Prieto R, Gil-de-Miguel Á. Incidence, mortality, and lethality of hospitalizations for
community-acquired pneumonia with comorbid cardiovascular disease in Spain (1997-2015). BMC
Infect Dis. 2020 Jul 6;20(1):477. doi: 10.1186/s12879-020-05208-y.
Gil-Prieto R, Walter S, San-Román-Montero J, Marín-García P, González-Escalada A, Gil-de-Miguel A.
Paediatric hospitalizations due to whooping cough in Spain (1997-2017). Vaccine. 2019 Oct
8;37(43):6342-6347. doi: 10.1016/j.vaccine.2019.09.017. Epub 2019 Sep 13.
San-Román-Montero JM, Gil Prieto R, Gallardo Pino C, Hinojosa Mena J, Zapatero Gaviria A, Gil de Miguel A.
Inpatient hospital fatality related to coding (ICD-9-CM) of the influenza diagnosis in Spain (2009-
2015). BMC Infect Dis. 2019 Aug 7;19(1):700. doi: 10.1186/s12879-019-4308-5.
Arias Fernández L, Pardo Seco J, Cebey-López M, Gil Prieto R, Rivero-Calle I, Martinon-Torres F, Gil de
Miguel Á; NEUMOEXPERTOS group, Martinón-Torres F, Vargas D, Mascarós E, Redondo E, Díaz-
Maroto JL, Linares-Rufo M, Gil A, Molina J, Ocaña D, Rivero-Calle I. Differences between diabetic
and non-diabetic patients with community-acquired pneumonia in primary care in Spain. BMC Infect
Dis. 2019 Nov 15;19(1):973. doi: 10.1186/s12879-019-4534-x.
López N, Gil-de-Miguel Á, Pascual-García R, Ramón Y Cajal JM, Gil-Prieto R. Hospitalization burden
associated with malignant neoplasia and in situ carcinoma in vulva and vagina during a 5-year period
(2009-2013) in Spain: An epidemiological study. Papillomavirus Res. 2018 Jun;5:80-86. doi:
10.1016/j.pvr.2018.02.001. Epub 2018 Feb 16.
López N, Gil-de-Miguel Á, Pascual-García R, Gil-Prieto R. Reduction in the burden of hospital admissions due
to cervical disease from 2003-2014 in Spain. Hum Vaccin Immunother. 2018 Apr 3;14(4):917-923. doi:
10.1080/21645515.2017.1412897. Epub 2017 Dec 21.